Market cap
₹4 Cr
Revenue (TTM)
₹0 Cr
P/E Ratio
299.5
P/B Ratio
0.8
Div. Yield
0 %
Stock Range
Today’s Range
52 Week Range
Liquidity
Fundamentals
-
Net Profit (TTM)
₹0 Cr
-
ROE
0.1 %
-
ROCE
0.1 %
-
Industry P/E
26.04
-
EV/EBITDA
195
-
Debt to Equity
0
-
Book Value
₹0.8
-
EPS
₹0
-
Face value
1
-
Shares outstanding
66,069,000
10 Years Aggregate
CFO
₹3.02 Cr
EBITDA
₹-1.98 Cr
Net Profit
₹-1.18 Cr
Performance
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
Amerise Bioscience
| 11.5 | -8.1 | 13.3 | -21.8 | 0.0 | -- | -15.8 |
|
BSE Finance
| -9.3 | -3.3 | -5.0 | -6.7 | 8.9 | 8.7 | 11.6 |
|
Company
|
2025
|
2024
|
2023
|
2022
|
|---|---|---|---|---|
|
Amerise Bioscience
| -52.0 | 68.1 | -27.1 | -48.9 |
|
BSE Small Cap
| -6.6 | 29.0 | 47.5 | -1.8 |
|
BSE Finance
| 15.7 | 8.7 | 17.1 | 11.1 |
Essential Checks
View DetailsIs there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
Financials
View DetailsKey Ratios
View Details
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Peers
View DetailsCompany |
Price (₹) | Market Cap (₹ Cr) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
Amerise Bioscience
|
0.7 | 4.5 | 0.1 | 0.0 | -63.6 | 0.4 | 299.5 | 0.8 |
| 71.2 | 1,577.3 | 2,727.6 | 209.9 | 10.4 | 12.7 | 8.8 | 1.1 | |
| 432.5 | 1,632.3 | 76.3 | -28.2 | 83.5 | 3.6 | 5.8 | 0.2 | |
| 788.3 | 487.8 | 386.9 | -127.5 | -28.4 | 0.4 | 27.1 | 0.2 | |
| 108.3 | 1,005.5 | 72.8 | 3.5 | -2.7 | 6.9 | -- | 6.1 | |
| 1,146.9 | 1,175.8 | 12.6 | 3.8 | 95.3 | -2.2 | -- | 1.2 | |
| 9,166.8 | 12,488.9 | -6.8 | -7.8 | 106.4 | -84.3 | -- | 1,443.6 | |
| 524.9 | 973.8 | 27.0 | 20.1 | 97.1 | 1.2 | 49 | 0.6 | |
| 940.2 | 1,006.9 | 68.4 | 38.3 | 71.7 | 25.7 | 26 | 6.7 | |
| 1,851.8 | 676.7 | 5.2 | 3.0 | 77.6 | 0.4 | 223.3 | 1.0 |
Shareholding Pattern
View DetailsNews & Analysis
All NewsNo Review & Analysis are available.
About Amerise Bioscience
Amradeep Industries Limited does not have significant operations. Previously, it was engaged in the commodity trading business. The company was incorporated in 1984 and is based in Ahmedabad, India.
-
Incorporated
1984
-
Chairman
--
-
Managing Director
--
-
Headquarters
Ahmedabad, Gujarat
-
Website
Annual Reports
FAQs for Amerise Bioscience
What is the current share price of Amerise Biosciences Ltd Today?
The share price of Amerise Biosciences Ltd is ₹0.74 (BSE) as of 09-Jun-2026 16:01 IST. Amerise Biosciences Ltd has given a return of 0% in the last 3 years.
What is the current PB & PE ratio of Amerise Biosciences Ltd?
The P/E ratio of Amerise Biosciences Ltd is 299.51 times as on 09-Jun-2026, a 1050 premium to its peers’ median range of 26.04 times.
The P/B ratio of Amerise Biosciences Ltd is 0.83 times as on 09-Jun-2026, a 28 discount to its peers’ median range of 1.15 times.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
|
2025
|
1,011.11
|
1.12
|
|
2024
|
0.00
|
0.81
|
|
2023
|
0.00
|
0.84
|
|
2022
|
16.37
|
1.59
|
|
2021
|
0.00
|
2.14
|
What is the 52 Week High and Low of Amerise Biosciences Ltd?
The 52-week high and low of Amerise Biosciences Ltd are Rs 0.93 and Rs 0.50 as of 10-Jun-2026.
What is the market cap of Amerise Biosciences Ltd?
Amerise Biosciences Ltd has a market capitalisation of ₹ 4 Cr as on 09-Jun-2026. As per SEBI classification, it is a Small Cap company.
Should I invest in Amerise Biosciences Ltd?
Before investing in Amerise Biosciences Ltd, assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.